Literatur
- 1
Entius M M, Keller J J, Drillenburg P. et al .
Microsatellite instability and expression of hMLH-1 and hMSH-2 in sebaceous gland
carcinomas as markers for Muir-Torre syndrome.
Clin Cancer Res.
2000;
6
1784-1789
- 2
Font R L, Rishi K.
Sebaceous gland adenoma of the tarsal conjunctiva in a patient with Muir-Torre syndrome.
Ophthalmology.
2003;
110
1833-1836
- 3
Kruse R, Rütten A, Hosseiny-Malayeri H R. et al .
”Second hit” in sebaceous tumors from Muir-Torre patients with germline mutations
in MSH2: allele loss is not the preferred mode of inactivation.
J Invest Dermatol.
2001;
116
463-465
- 4
Mathiak M, Rütten A, Mangold E. et al .
Loss of DNA mismatch repair proteins in skin tumors from patients with Muir-Torre
syndrome and MSH2 or MLH1 germline mutations: establishment of immunohistochemical
analysis as a screening test.
Am J Surg Pathol.
2002;
26
338-343
- 5
Meier-Gibbons F, Messmer E.
Sebaceous gland adenoma of the palpebral conjunctiva in a patient with Muir-Torre-syndrome:
a case report.
Graefe’s Arch Clin Exp Ophthalmol.
1994;
232
734-736
- 6
Muir E G, Bell A J, Barlow K A.
Multiple primary carcinomata of the colon, duodenum, and larynx associated with kerato-acanthomata
of the face.
Brit J Surg.
1967;
54
191-195
- 7
Popnikolov N K, Gatalica Z, Colome-Grimmer M I. et al .
Loss of mismatch repair proteins in sebaceous gland tumors.
J Cutan Pathol.
2003;
30
178-184
- 8
Shields C L, Shields J A, White D. et al .
Types and frequency of lesions of the caruncle.
Am J Ophthalmol.
1986;
102
771-778
- 9
Torre D.
Multiple sebaceous Tumors..
Arch Dermatol.
1968;
98
549-551
Dr. Takahiko Sakuma
Abteilung der klinischen Pathologie, Osaka Rosai Krankenhaus
1179-3 Nagasone Kita
Sakai Osaka 591-8025
Japan
Phone: ++ 81/72/2 52 35 61 e xt 36 90
Fax: ++ 81/72/2 55 33 49
Email: thsakuma@orh.go.jp